{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T18:22:27Z","timestamp":1791397347686,"version":"4.3.3"},"reference-count":38,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,1,29]],"date-time":"2024-01-29T00:00:00Z","timestamp":1706486400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100011077","name":"Sk\u00e5nes universitetssjukhus","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011077","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003252","name":"Lunds Universitet","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003252","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","valueinhealthjournal.com","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Value in Health"],"published-print":{"date-parts":[[2024,4]]},"DOI":"10.1016\/j.jval.2024.01.007","type":"journal-article","created":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T20:50:12Z","timestamp":1706820612000},"page":"425-432","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Cost of Illness of Head and Neck Cancer in Sweden"],"prefix":"10.1016","volume":"27","author":[{"given":"Maria","family":"Silfverschi\u00f6ld","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johan","family":"Jarl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Hafstr\u00f6m","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lennart","family":"Greiff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johanna","family":"Sj\u00f6vall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.jval.2024.01.007_bib1","doi-asserted-by":"crossref","first-page":"489","DOI":"10.4065\/83.4.489","article-title":"Head and neck cancer: changing epidemiology, diagnosis, and treatment","volume":"83","author":"Marur","year":"2008","journal-title":"Mayo Clin Proc"},{"issue":"3","key":"10.1016\/j.jval.2024.01.007_bib2","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.anorl.2019.04.002","article-title":"Head and neck carcinoma of unknown primary","volume":"136","author":"Kennel","year":"2019","journal-title":"Eur Ann Otorhinolaryngol Head Neck Dis"},{"issue":"3","key":"10.1016\/j.jval.2024.01.007_bib3","doi-asserted-by":"crossref","first-page":"209","DOI":"10.3322\/caac.21660","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"issue":"8","key":"10.1016\/j.jval.2024.01.007_bib5","doi-asserted-by":"crossref","first-page":"653","DOI":"10.2165\/11588380-000000000-00000","article-title":"Cost-of-illness studies: a guide to critical evaluation","volume":"29","author":"Larg","year":"2011","journal-title":"Pharmacoeconomics"},{"issue":"3","key":"10.1016\/j.jval.2024.01.007_bib6","doi-asserted-by":"crossref","first-page":"429","DOI":"10.2307\/3349801","article-title":"Cost-of-illness methodology: a guide to current practices and procedures","volume":"60","author":"Hodgson","year":"1982","journal-title":"Milbank Mem Fund Q Health Soc"},{"issue":"9","key":"10.1016\/j.jval.2024.01.007_bib7","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1007\/s40273-014-0169-3","article-title":"The economic burden of head and neck cancer: a systematic literature review","volume":"32","author":"Wissinger","year":"2014","journal-title":"Pharmacoeconomics"},{"issue":"5-6","key":"10.1016\/j.jval.2024.01.007_bib8","doi-asserted-by":"crossref","first-page":"e400","DOI":"10.1093\/milmed\/usy192","article-title":"Cost and healthcare utilization among non-elderly head and neck cancer patients in the Military Health System, a single-payer universal health care model","volume":"184","author":"Ambrosio","year":"2019","journal-title":"Mil Med"},{"issue":"12","key":"10.1016\/j.jval.2024.01.007_bib9","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1001\/jamaoto.2015.2162","article-title":"The cost of hospice services in terminally ill patients with head and neck cancer","volume":"141","author":"Enomoto","year":"2015","journal-title":"JAMA Otolaryngol Head Neck Surg"},{"issue":"3","key":"10.1016\/j.jval.2024.01.007_bib10","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1177\/0194599819846072","article-title":"End-of-life costs and hospice utilization in patients with head and neck cancer","volume":"161","author":"Chen","year":"2019","journal-title":"Otolaryngol Head Neck Surg"},{"key":"10.1016\/j.jval.2024.01.007_bib11","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.ejca.2017.07.054","article-title":"Cost-effectiveness analysis of PET-CT-guided management for locally advanced head and neck cancer","volume":"85","author":"Smith","year":"2017","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.jval.2024.01.007_bib12","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.oraloncology.2017.09.017","article-title":"Cost-effectiveness of nivolumab for recurrent or metastatic head and neck cancer","volume":"74","author":"Ward","year":"2017","journal-title":"Oral Oncol"},{"issue":"5","key":"10.1016\/j.jval.2024.01.007_bib13","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1017\/S0266462320000677","article-title":"Cost-effectiveness of treating head and neck cancer using intensity-modulated radiation therapy: implications for cancer control program in India","volume":"36","author":"Chauhan","year":"2020","journal-title":"Int J Technol Assess Health Care"},{"issue":"4","key":"10.1016\/j.jval.2024.01.007_bib14","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1016\/j.clinthera.2018.02.010","article-title":"Patient characteristics and costs in recurrent or refractory head and neck cancer: retrospective analysis of a community oncology database","volume":"40","author":"Fisher","year":"2018","journal-title":"Clin Ther"},{"issue":"7","key":"10.1016\/j.jval.2024.01.007_bib15","first-page":"698","article-title":"Economic burden of chemotherapy-treated recurrent and\/or metastatic squamous cell carcinoma of the head and neck in France: real-world data from the permanent sample of national health insurance beneficiaries","volume":"22","author":"Lafuma","year":"2019","journal-title":"J\u00a0Med Econ"},{"issue":"2","key":"10.1016\/j.jval.2024.01.007_bib16","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1001\/jamafacial.2018.1197","article-title":"Risk factors, causes, and costs of hospital readmission after head and neck cancer surgery reconstruction","volume":"21","author":"Goel","year":"2019","journal-title":"JAMA Facial Plast Surg"},{"issue":"7","key":"10.1016\/j.jval.2024.01.007_bib17","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1111\/jop.12907","article-title":"The economic burden of oral squamous cell carcinoma in Australia","volume":"48","author":"Pollaers","year":"2019","journal-title":"J\u00a0Oral Pathol Med"},{"key":"10.1016\/j.jval.2024.01.007_bib18","doi-asserted-by":"crossref","first-page":"441","DOI":"10.2147\/CEOR.S198312","article-title":"Clinical and economic burden of head and neck cancer: a nationwide retrospective cohort study from France","volume":"11","author":"Schernberg","year":"2019","journal-title":"Clinicoecon Outcomes Res"},{"issue":"4","key":"10.1016\/j.jval.2024.01.007_bib19","first-page":"421","article-title":"Economic burden of resected squamous cell carcinoma of the head and neck in a US managed-care population","volume":"14","author":"Amonkar","year":"2011","journal-title":"J\u00a0Med Econ"},{"issue":"2","key":"10.1016\/j.jval.2024.01.007_bib20","doi-asserted-by":"crossref","first-page":"403","DOI":"10.31557\/APJCP.2019.20.2.403","article-title":"Economic burden of head and neck cancer treatment in North India","volume":"20","author":"Chauhan","year":"2019","journal-title":"Asian Pac J Cancer Prev"},{"issue":"2","key":"10.1016\/j.jval.2024.01.007_bib21","doi-asserted-by":"crossref","first-page":"159","DOI":"10.2165\/00019053-199711020-00005","article-title":"Guidelines for pharmacoeconomic studies. Recommendations from the panel on cost effectiveness in health and medicine. Panel on cost effectiveness in Health and Medicine","volume":"11","author":"Siegel","year":"1997","journal-title":"Pharmacoeconomics"},{"issue":"1","key":"10.1016\/j.jval.2024.01.007_bib25","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1186\/s12913-020-05265-8","article-title":"The economic burden of prostate cancer - a Swedish prevalence-based register study","volume":"20","author":"Hao","year":"2020","journal-title":"BMC Health Serv Res"},{"issue":"6","key":"10.1016\/j.jval.2024.01.007_bib26","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.oraloncology.2010.03.010","article-title":"Dental treatment planning and management for the mouth cancer patient","volume":"46","author":"Joshi","year":"2010","journal-title":"Oral Oncol"},{"issue":"5","key":"10.1016\/j.jval.2024.01.007_bib27","first-page":"e524","article-title":"Periodontal therapy for patients before and after radiotherapy: a review of the literature and topics of interest for clinicians","volume":"23","author":"Irie","year":"2018","journal-title":"Med Oral Patol Oral Cir Bucal"},{"issue":"4","key":"10.1016\/j.jval.2024.01.007_bib28","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1093\/ije\/dyt088","article-title":"Data resource profile: the survey of health, ageing and retirement in Europe (SHARE)","volume":"42","author":"B\u00f6rsch-Supan","year":"2013","journal-title":"Int J Epidemiol"},{"issue":"2","key":"10.1016\/j.jval.2024.01.007_bib29","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/0168-8510(91)90095-F","article-title":"The costs of treating hypertension--an analysis of different cut-off points","volume":"18","author":"Johannesson","year":"1991","journal-title":"Health Policy"},{"issue":"1","key":"10.1016\/j.jval.2024.01.007_bib30","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1186\/s12913-021-07264-9","article-title":"Cost analysis of informal care: estimates from a national cross-sectional survey in Sweden","volume":"21","author":"Ekman","year":"2021","journal-title":"BMC Health Serv Res"},{"issue":"9","key":"10.1016\/j.jval.2024.01.007_bib31","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0203059","article-title":"The economic burden of oral cancer in Iran","volume":"13","author":"Rezapour","year":"2018","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.jval.2024.01.007_bib32","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0179520","article-title":"The economic burden of human papillomavirus-related precancers and cancers in Sweden","volume":"12","author":"Ostensson","year":"2017","journal-title":"PLoS One"},{"issue":"7","key":"10.1016\/j.jval.2024.01.007_bib33","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1080\/0284186X.2021.1892821","article-title":"Projected economic burden of pancreatic cancer in Sweden in 2030","volume":"60","author":"Draus","year":"2021","journal-title":"Acta Oncol"},{"issue":"3","key":"10.1016\/j.jval.2024.01.007_bib34","doi-asserted-by":"crossref","first-page":"347","DOI":"10.2340\/00015555-1938","article-title":"Societal cost of skin cancer in Sweden in 2011","volume":"95","author":"Eriksson","year":"2015","journal-title":"Acta Derm Venereol"},{"issue":"6","key":"10.1016\/j.jval.2024.01.007_bib35","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1002\/hed.25585","article-title":"Changes in incidence and prevalence of human papillomavirus in tonsillar and base of tongue cancer during 2000-2016 in the Stockholm region and Sweden","volume":"41","author":"Haeggblom","year":"2019","journal-title":"Head Neck"},{"issue":"1","key":"10.1016\/j.jval.2024.01.007_bib36","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.ejca.2014.10.016","article-title":"Incidence of human papillomavirus positive tonsillar and base of tongue carcinoma: a stabilisation of an epidemic of viral induced carcinoma?","volume":"51","author":"N\u00e4sman","year":"2015","journal-title":"Eur J Cancer"},{"issue":"1","key":"10.1016\/j.jval.2024.01.007_bib37","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/s10198-023-01578-7","article-title":"Cost-effectiveness analysis of (accelerated) pre-operative versus (conventional) post-operative radiotherapy for patients with oral cavity cancer in Sweden","volume":"25","author":"Silfverschi\u00f6ld","year":"2024","journal-title":"Eur J Health Econ"},{"issue":"2","key":"10.1016\/j.jval.2024.01.007_bib38","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/0167-6296(94)00044-5","article-title":"The friction cost method for measuring indirect costs of disease","volume":"14","author":"Koopmanschap","year":"1995","journal-title":"J\u00a0Health Econ"},{"issue":"1","key":"10.1016\/j.jval.2024.01.007_bib39","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s10198-014-0652-y","article-title":"Estimating productivity costs using the friction cost approach in practice: a systematic review","volume":"17","author":"Kigozi","year":"2016","journal-title":"Eur J Health Econ"},{"issue":"7","key":"10.1016\/j.jval.2024.01.007_bib40","doi-asserted-by":"crossref","first-page":"2437","DOI":"10.1007\/s00405-020-06326-8","article-title":"Correlations between long-term quality of life and patient needs and concerns following head and neck cancer treatment and the impact of psychological distress. a multicentric cross-sectional study","volume":"278","author":"Elaldi","year":"2021","journal-title":"Eur Arch Oto-Rhino-Laryngol"},{"issue":"1","key":"10.1016\/j.jval.2024.01.007_bib41","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1002\/lio2.702","article-title":"Head and neck cancer survivorship consensus statement from the American Head and Neck Society","volume":"7","author":"Goyal","year":"2022","journal-title":"Laryngoscope Investig Otolaryngol"},{"issue":"5","key":"10.1016\/j.jval.2024.01.007_bib42","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1007\/s40273-017-0490-8","article-title":"Making implicit assumptions explicit in the costing of informal care: the case of head and neck cancer in Ireland","volume":"35","author":"Hanly","year":"2017","journal-title":"Pharmacoeconomics"}],"container-title":["Value in Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1098301524000366?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1098301524000366?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,10,31]],"date-time":"2024-10-31T16:09:57Z","timestamp":1730390997000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1098301524000366"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4]]},"references-count":38,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,4]]}},"alternative-id":["S1098301524000366"],"URL":"https:\/\/doi.org\/10.1016\/j.jval.2024.01.007","relation":{},"ISSN":["1098-3015"],"issn-type":[{"value":"1098-3015","type":"print"}],"subject":[],"published":{"date-parts":[[2024,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cost of Illness of Head and Neck Cancer in Sweden","name":"articletitle","label":"Article Title"},{"value":"Value in Health","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jval.2024.01.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 International Society for Pharmacoeconomics and Outcomes Research, Inc. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}